Narlumosbart

DB19002InvestigationalProtein Based Therapies

Narlumosbart is under investigation in clinical trial NCT06314698 (Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease).

Mechanism: Pharmacologically active on Tumor necrosis factor ligand superfamily member 11
Curator reviewed
Code names: JMT-103

Resolves to

Compound

UNIIJ38KT46AH8CAS2646587-68-8

Targets

O14788TNFSF11

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Narlumosbart, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account